首页 > 最新文献

International Journal of Endocrinology最新文献

英文 中文
Evaluation of the Quality of Life in Moroccan Patients Diagnosed with Hypoparathyroidism 评估摩洛哥甲状旁腺功能减退症患者的生活质量
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-16 DOI: 10.1155/2024/7337895
Mohammed-Amine Essafi, Samira Handa, Hayat Aynaou, Houda Salhi
<i>Objective</i>. Hypoparathyroidism (HPt) is a rare endocrine disorder often of postsurgical origin, resulting in hypocalcaemia. Several complications have been described including impairment of quality of life (QoL). Our study aims to evaluate the effect of hypoparathyroidism on the QoL of patients diagnosed with HPt. <i>Methods</i>. A cross-sectional study was conducted in the Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition of the Hassan II University Hospital of Fez. We included in our study all patients followed for chronic HPt. Well-being was assessed using the WHO 5 index, and QoL was assessed by the SF-36 questionnaire in its validated Arabic version. Data were entered into Excel and analysed using SPSS 26. Multiple linear regression was utilized to ascertain the variables linked to the QoL in individuals diagnosed with HPt. <i>Results</i>. A total of 143 patients with HPt were included in the study, 86.7% of whom were female. The mean age of the patients was 44.6 ± 17.3 years. 89.9% were of postsurgical etiology. The assessment of well-being by the WHO 5 index showed a low score (<50), meaning poor well-being in 44.8%. Regarding the QoL, the assessment showed low scores in the areas of general health (41.7), limitations due to physical condition (40.5), vitality (41.4), and limitations due to psychological condition (42.6). The multiple linear regression model revealed a noteworthy association between low SF-36 score and advanced age (<i>β</i> = −5.91; <span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 18.973 11.7782" width="18.973pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"></path></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"></path></g></svg><span></span><span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="22.555183800000002 -8.34882 28.184 11.7782" width="28.184pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,22.605,0)"></path></g><g transform="matrix(.013,0,0,-0.013,28.845,0)"></path></g><g transform="matrix(.013,0,0,-0.013,31.809,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,38.049,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,44.289,0)"></path></g></svg>),</span></span> surgical etiology (<i>β</i> = 8.71; <span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 18.973 11.7782" width="18.973pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><use xlink:href="#g113-113"></use></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"><use xlink:href="#g117-91"></use></g></svg><span></span><span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="22.555183800
目的:甲状旁腺功能减退症(HPt甲状旁腺功能减退症(HPt)是一种罕见的内分泌疾病,通常源于手术后,会导致低钙血症。已描述的几种并发症包括生活质量(QoL)受损。我们的研究旨在评估甲状旁腺功能减退症对确诊为甲状旁腺功能减退症(HPt)患者生活质量的影响。我们在非斯哈桑二世大学医院内分泌学、糖尿病学、代谢疾病和营养学部门开展了一项横断面研究。我们将所有慢性 HPt 患者都纳入了研究范围。幸福指数采用世界卫生组织 5 指数进行评估,QoL 采用 SF-36 问卷的阿拉伯语有效版本进行评估。数据输入 Excel,并使用 SPSS 26 进行分析。利用多元线性回归确定与确诊为 HPt 患者的 QoL 相关的变量。结果。本研究共纳入 143 名 HPt 患者,其中 86.7% 为女性。患者的平均年龄为(44.6 ± 17.3)岁。89.9%为手术后病因。根据世界卫生组织 5 项指数进行的幸福感评估显示,44.8% 的患者幸福感较低(50 分),即幸福感较差。在生活质量方面,评估显示一般健康(41.7)、身体状况限制(40.5)、活力(41.4)和心理状况限制(42.6)方面得分较低。多元线性回归模型显示,SF-36 低分与高龄(β = -5.91;)、手术病因(β = 8.71;)、受教育程度低(β = -10.1;)和服药依从性差(β = -11.3;)之间存在显著关联。然而,QoL受损与达到正常钙血症之间的关系并不显著()。结论。我们的工作目标是,HPt 患者的 QoL 会降低,而且是由多种因素造成的。尽管钙血症正常,但假设甲状旁腺激素会直接影响 QoL。这些结果可作为今后研究的基础。
{"title":"Evaluation of the Quality of Life in Moroccan Patients Diagnosed with Hypoparathyroidism","authors":"Mohammed-Amine Essafi, Samira Handa, Hayat Aynaou, Houda Salhi","doi":"10.1155/2024/7337895","DOIUrl":"https://doi.org/10.1155/2024/7337895","url":null,"abstract":"&lt;i&gt;Objective&lt;/i&gt;. Hypoparathyroidism (HPt) is a rare endocrine disorder often of postsurgical origin, resulting in hypocalcaemia. Several complications have been described including impairment of quality of life (QoL). Our study aims to evaluate the effect of hypoparathyroidism on the QoL of patients diagnosed with HPt. &lt;i&gt;Methods&lt;/i&gt;. A cross-sectional study was conducted in the Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition of the Hassan II University Hospital of Fez. We included in our study all patients followed for chronic HPt. Well-being was assessed using the WHO 5 index, and QoL was assessed by the SF-36 questionnaire in its validated Arabic version. Data were entered into Excel and analysed using SPSS 26. Multiple linear regression was utilized to ascertain the variables linked to the QoL in individuals diagnosed with HPt. &lt;i&gt;Results&lt;/i&gt;. A total of 143 patients with HPt were included in the study, 86.7% of whom were female. The mean age of the patients was 44.6 ± 17.3 years. 89.9% were of postsurgical etiology. The assessment of well-being by the WHO 5 index showed a low score (&lt;50), meaning poor well-being in 44.8%. Regarding the QoL, the assessment showed low scores in the areas of general health (41.7), limitations due to physical condition (40.5), vitality (41.4), and limitations due to psychological condition (42.6). The multiple linear regression model revealed a noteworthy association between low SF-36 score and advanced age (&lt;i&gt;β&lt;/i&gt; = −5.91; &lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.34882 18.973 11.7782\" width=\"18.973pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.342,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"22.555183800000002 -8.34882 28.184 11.7782\" width=\"28.184pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,22.605,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,28.845,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,31.809,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,38.049,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,44.289,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;),&lt;/span&gt;&lt;/span&gt; surgical etiology (&lt;i&gt;β&lt;/i&gt; = 8.71; &lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.34882 18.973 11.7782\" width=\"18.973pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;use xlink:href=\"#g113-113\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.342,0)\"&gt;&lt;use xlink:href=\"#g117-91\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"22.555183800","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"43 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140568600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolomics of Mice with Type 2 Diabetes and Nonalcoholic Fatty Liver Treated by Acupuncture 针灸治疗 2 型糖尿病和非酒精性脂肪肝小鼠的代谢组学研究
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-10 DOI: 10.1155/2024/5568337
Yihui Guo, Liying Zhang, Mengyuan Li, Linan Lin, Fuyu Xue, Wanning Gao, Xiaoru Xu, Haipeng Huang
Introduction. To investigate the effects of acupuncture on endogenous metabolites in the liver of type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver disease (NAFLD) mice-based metabolomics. Methods. Proton nuclear magnetic resonance (1H-NMR) metabolomics combined with multivariate statistical analysis and univariate analysis were used to analyze the changes of endogenous metabolites in the liver of mice in each group and to provide new clinical ideas for acupuncture in the treatment of glycolipid metabolism disorders caused by T2DM and NAFLD. Results. After 4 weeks of continuous treatment, fasting blood glucose (FBG), insulin (INS), total cholesterol (TC), and triglyceride (TG) decreased significantly in mice in the acupuncture treatment group (ATG), and the content of liver glycogen increased significantly. Based on 1H-NMR metabolomic analysis, a total of 47 metabolites were identified in the liver of T2DM with NAFLD mice, of which eight metabolites: UDP-N-acetylglucosamine, adenosine, glutamate, isoleucine, ATP, 3-hydroxybutyric acid, NADP+, and leucine were significantly altered by acupuncture treatment. Through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, it is found that acupuncture has an intervention effect on five metabolic pathways, mainly involving amino acid metabolism, energy metabolism, and oxidative stress. Conclusion. Our study shows that acupuncture can regulate the liver metabolism mode of T2DM in NAFLD mice. It can reduce blood glucose and lipid accumulation in the liver, and these findings provide a new idea and theoretical basis for acupuncture in the treatment of diseases related to glucose and lipid metabolism.
引言研究针灸对 2 型糖尿病(T2DM)合并非酒精性脂肪肝(NAFLD)小鼠肝脏内源性代谢物的影响。方法:质子核磁共振(1采用质子核磁共振(1H-NMR)代谢组学方法,结合多元统计分析和单变量分析,分析各组小鼠肝脏内源性代谢物的变化,为针灸治疗T2DM和非酒精性脂肪肝引起的糖脂代谢紊乱提供新的临床思路。研究结果连续治疗4周后,针灸治疗组(ATG)小鼠空腹血糖(FBG)、胰岛素(INS)、总胆固醇(TC)和甘油三酯(TG)明显下降,肝糖原含量明显升高。通过 1H-NMR 代谢组学分析,在 T2DM 伴非酒精性脂肪肝小鼠肝脏中共鉴定出 47 种代谢物,其中 8 种代谢物为:UDP-N-乙酰葡萄糖:其中8种代谢物:UDP-N-乙酰葡萄糖胺、腺苷、谷氨酸、异亮氨酸、ATP、3-羟基丁酸、NADP+和亮氨酸在针灸治疗后发生了显著变化。通过京都基因组百科全书(KEGG)通路分析发现,针灸对五种代谢通路有干预作用,主要涉及氨基酸代谢、能量代谢和氧化应激。结论我们的研究表明,针灸可以调节非酒精性脂肪肝小鼠 T2DM 的肝脏代谢模式。这些研究结果为针灸治疗糖脂代谢相关疾病提供了新的思路和理论依据。
{"title":"Metabolomics of Mice with Type 2 Diabetes and Nonalcoholic Fatty Liver Treated by Acupuncture","authors":"Yihui Guo, Liying Zhang, Mengyuan Li, Linan Lin, Fuyu Xue, Wanning Gao, Xiaoru Xu, Haipeng Huang","doi":"10.1155/2024/5568337","DOIUrl":"https://doi.org/10.1155/2024/5568337","url":null,"abstract":"<i>Introduction</i>. To investigate the effects of acupuncture on endogenous metabolites in the liver of type 2 diabetes mellitus (T2DM) with nonalcoholic fatty liver disease (NAFLD) mice-based metabolomics. <i>Methods</i>. Proton nuclear magnetic resonance (<sup>1</sup>H-NMR) metabolomics combined with multivariate statistical analysis and univariate analysis were used to analyze the changes of endogenous metabolites in the liver of mice in each group and to provide new clinical ideas for acupuncture in the treatment of glycolipid metabolism disorders caused by T2DM and NAFLD. <i>Results</i>. After 4 weeks of continuous treatment, fasting blood glucose (FBG), insulin (INS), total cholesterol (TC), and triglyceride (TG) decreased significantly in mice in the acupuncture treatment group (ATG), and the content of liver glycogen increased significantly. Based on <sup>1</sup>H-NMR metabolomic analysis, a total of 47 metabolites were identified in the liver of T2DM with NAFLD mice, of which eight metabolites: UDP-N-acetylglucosamine, adenosine, glutamate, isoleucine, ATP, 3-hydroxybutyric acid, NADP<sup>+</sup>, and leucine were significantly altered by acupuncture treatment. Through the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, it is found that acupuncture has an intervention effect on five metabolic pathways, mainly involving amino acid metabolism, energy metabolism, and oxidative stress. <i>Conclusion</i>. Our study shows that acupuncture can regulate the liver metabolism mode of T2DM in NAFLD mice. It can reduce blood glucose and lipid accumulation in the liver, and these findings provide a new idea and theoretical basis for acupuncture in the treatment of diseases related to glucose and lipid metabolism.","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"12 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140568334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parathyroid Hormone is Negatively Correlated with Glycated Hemoglobin in Newly Diagnosed Type 2 Diabetic Patients 甲状旁腺激素与新诊断的 2 型糖尿病患者的糖化血红蛋白呈负相关
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-01 DOI: 10.1155/2024/8414689
Xueqing He, Man Liu, Xiaoyu Ding, Nannan Bian, Jiaxuan Wang, Guang Wang, Jia Liu
<i>Objective</i>. The growing evidence shows that parathyroid hormone (PTH) may affect glucose metabolism. However, the relationship between them is still controversial among diabetic patients. The current study aimed to investigate the relationship between PTH and glucose metabolism in the patients with newly diagnosed type 2 diabetes (T2D). <i>Methods</i>. A total of 532 participants, including 387 patients with newly diagnosed T2D and 145 healthy controls, were recruited in the present study. PTH and metabolic parameters were measured in all participants. <i>Results</i>. The PTH levels were significantly lower in the newly diagnosed T2D patients compared with the control group (35.10 (25.90, 47.20) vs. 47.15 (35.83, 58.65) pg/ml, <span><svg height="9.2729pt" style="vertical-align:-0.6370001pt" version="1.1" viewbox="-0.0498162 -8.6359 19.289 9.2729" width="19.289pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"></path></g><g transform="matrix(.013,0,0,-0.013,11.658,0)"></path></g></svg><span></span><span><svg height="9.2729pt" style="vertical-align:-0.6370001pt" version="1.1" viewbox="22.8711838 -8.6359 28.182 9.2729" width="28.182pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,22.921,0)"></path></g><g transform="matrix(.013,0,0,-0.013,29.161,0)"></path></g><g transform="matrix(.013,0,0,-0.013,32.125,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,38.365,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,44.605,0)"></path></g></svg>).</span></span> The T2D patients with a higher glycated hemoglobin (HbA1c) tertile had lower PTH levels than the patients with a lower HbA1c tertile (32.90 (24.85, 41.40) vs. 37.50 (26.10, 54.55) pg/ml, <span><svg height="9.2729pt" style="vertical-align:-0.6370001pt" version="1.1" viewbox="-0.0498162 -8.6359 19.289 9.2729" width="19.289pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><use xlink:href="#g113-81"></use></g><g transform="matrix(.013,0,0,-0.013,11.658,0)"><use xlink:href="#g117-91"></use></g></svg><span></span><span><svg height="9.2729pt" style="vertical-align:-0.6370001pt" version="1.1" viewbox="22.8711838 -8.6359 28.182 9.2729" width="28.182pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,22.921,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,29.161,0)"><use xlink:href="#g113-47"></use></g><g transform="matrix(.013,0,0,-0.013,32.125,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,38.365,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,44.605,0)"><use xlink:href="#g113-50"></use></g></svg>).</span></span> Spearman correlation analysis showed that PTH was positively correla
目的。越来越多的证据表明,甲状旁腺激素(PTH)可能会影响糖代谢。然而,两者之间的关系在糖尿病患者中仍存在争议。本研究旨在探讨新诊断的 2 型糖尿病(T2D)患者体内甲状旁腺激素(PTH)与糖代谢之间的关系。研究方法本研究共招募了 532 名参与者,包括 387 名新诊断的 T2D 患者和 145 名健康对照者。对所有参与者的 PTH 和代谢参数进行了测量。结果显示新诊断的 T2D 患者的 PTH 水平明显低于对照组(35.10 (25.90, 47.20) vs. 47.15 (35.83, 58.65) pg/ml)。糖化血红蛋白(HbA1c)三分位数较高的 T2D 患者的 PTH 水平低于 HbA1c 三分位数较低的患者(32.90 (24.85, 41.40) vs. 37.50 (26.10, 54.55) pg/ml)。斯皮尔曼相关分析表明,PTH 与体重指数(BMI)、空腹胰岛素(FINS)、β 细胞功能稳态模型评估(HOMA-β)和胰岛素抵抗稳态模型评估(HOMA-IR)呈正相关,而与 HbA1c、血钙(Ca)、血磷(P)和 25- 羟维生素 D3(25-OH-D3)呈负相关。多元线性回归分析表明,在对年龄、性别、体重指数、季节、25-OH-D3、钙和磷进行调整后,PTH 与 HbA1c(β = -1.475, )和 HOMA-β (β = 0.090, )显著相关。在新诊断的 T2D 患者中,PTH 与 HbA1c 呈负相关。我们的研究结果表明,PTH水平在参考范围内与胰岛β细胞功能和高血糖有关。
{"title":"Parathyroid Hormone is Negatively Correlated with Glycated Hemoglobin in Newly Diagnosed Type 2 Diabetic Patients","authors":"Xueqing He, Man Liu, Xiaoyu Ding, Nannan Bian, Jiaxuan Wang, Guang Wang, Jia Liu","doi":"10.1155/2024/8414689","DOIUrl":"https://doi.org/10.1155/2024/8414689","url":null,"abstract":"&lt;i&gt;Objective&lt;/i&gt;. The growing evidence shows that parathyroid hormone (PTH) may affect glucose metabolism. However, the relationship between them is still controversial among diabetic patients. The current study aimed to investigate the relationship between PTH and glucose metabolism in the patients with newly diagnosed type 2 diabetes (T2D). &lt;i&gt;Methods&lt;/i&gt;. A total of 532 participants, including 387 patients with newly diagnosed T2D and 145 healthy controls, were recruited in the present study. PTH and metabolic parameters were measured in all participants. &lt;i&gt;Results&lt;/i&gt;. The PTH levels were significantly lower in the newly diagnosed T2D patients compared with the control group (35.10 (25.90, 47.20) vs. 47.15 (35.83, 58.65) pg/ml, &lt;span&gt;&lt;svg height=\"9.2729pt\" style=\"vertical-align:-0.6370001pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.6359 19.289 9.2729\" width=\"19.289pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.658,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"9.2729pt\" style=\"vertical-align:-0.6370001pt\" version=\"1.1\" viewbox=\"22.8711838 -8.6359 28.182 9.2729\" width=\"28.182pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,22.921,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,29.161,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,32.125,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,38.365,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,44.605,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;).&lt;/span&gt;&lt;/span&gt; The T2D patients with a higher glycated hemoglobin (HbA1c) tertile had lower PTH levels than the patients with a lower HbA1c tertile (32.90 (24.85, 41.40) vs. 37.50 (26.10, 54.55) pg/ml, &lt;span&gt;&lt;svg height=\"9.2729pt\" style=\"vertical-align:-0.6370001pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.6359 19.289 9.2729\" width=\"19.289pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;use xlink:href=\"#g113-81\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.658,0)\"&gt;&lt;use xlink:href=\"#g117-91\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"9.2729pt\" style=\"vertical-align:-0.6370001pt\" version=\"1.1\" viewbox=\"22.8711838 -8.6359 28.182 9.2729\" width=\"28.182pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,22.921,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,29.161,0)\"&gt;&lt;use xlink:href=\"#g113-47\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,32.125,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,38.365,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,44.605,0)\"&gt;&lt;use xlink:href=\"#g113-50\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;/svg&gt;).&lt;/span&gt;&lt;/span&gt; Spearman correlation analysis showed that PTH was positively correla","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"50 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140568330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of Combined Exposure to Metabolic and Inflammatory Indicators with Thyroid Nodules in Adults: A Nested Case-Control Study 代谢和炎症指标的综合暴露与成人甲状腺结节的关系:巢式病例对照研究
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-27 DOI: 10.1155/2024/3950894
Xin-Yi Zhu, Xing-Chen Meng, Bei-Jing Cheng, Chun Wang, Jia Wang, Tian-Lin Li, Hui Li, Ke Meng, Ran Liu
Objective. To explore associations of combined exposure to metabolic/inflammatory indicators with thyroid nodules. Methods. We reviewed personal data for health screenings from 2020 to 2021. A propensity score matching method was used to match 931 adults recently diagnosed with thyroid nodules in a 1 : 4 ratio based on age and gender. Conditional logistic regression and Bayesian kernel machine regression (BKMR) were used to explore the associations of single metabolic/inflammatory indicators and the mixture with thyroid nodules, respectively. Results. In the adjusted models, five indicators (ORQ4 vs. Q1: 1.30, 95% CI: 1.07–1.58 for fasting blood glucose; ORQ4 vs. Q1: 1.30, 95% CI: 1.08–1.57 for systolic blood pressure; ORQ4 vs. Q1: 1.26, 95% CI: 1.04–1.53 for diastolic blood pressure; ORQ4 vs. Q1: 1.23, 95% CI: 1.02–1.48 for white blood cell; ORQ4 vs. Q1: 1.28, 95% CI: 1.07–1.55 for neutrophil) were positively associated with the risk of thyroid nodules, while high-density lipoproteins (ORQ3 vs. Q1: 0.75, 95% CI: 0.61–0.91) were negatively associated with the risk of thyroid nodules. Univariate exposure-response functions from BKMR models showed similar results. Moreover, the metabolic and inflammatory mixture exhibited a significant positive association with thyroid nodules in a dose-response pattern, with systolic blood pressure being the greatest contributor within the mixture (conditional posterior inclusion probability of 0.82). No interaction effects were found among the five indicators. These associations were more prominent in males, participants with higher age (≥40 years old), and individuals with abnormal body mass index status. Conclusions. Levels of the metabolic and inflammatory mixture have a linear dose-response relationship with the risk of developing thyroid nodules, with systolic blood pressure levels being the most important contributor.
目的探讨代谢/炎症指标的综合暴露与甲状腺结节的关系。方法。我们回顾了 2020 年至 2021 年健康检查的个人数据。采用倾向得分匹配法,根据年龄和性别以 1 :4 的比例进行匹配。条件逻辑回归和贝叶斯核机器回归(BKMR)分别用于探讨单一代谢/炎症指标和混合指标与甲状腺结节的关系。结果显示在调整模型中,五个指标(空腹血糖 ORQ4 vs. Q1:1.30,95% CI:1.07-1.58;收缩压 ORQ4 vs. Q1:1.30,95% CI:1.08-1.57;舒张压 ORQ4 vs. Q1:1.26,95% CI:1.04-1.53;白细胞 ORQ4 vs. Q1:1.23,95% CI:1.02-1.而高密度脂蛋白(ORQ3 vs. Q1:0.75,95% CI:0.61-0.91)与甲状腺结节风险呈负相关。BKMR模型的单变量暴露-反应函数显示了类似的结果。此外,代谢和炎症混合物与甲状腺结节呈显著正相关,呈剂量-反应模式,收缩压是混合物中的最大贡献者(条件后纳入概率为 0.82)。五个指标之间没有发现交互效应。这些关联在男性、年龄较大(≥40 岁)的参与者和体重指数异常的个体中更为突出。结论代谢和炎症混合物的水平与甲状腺结节的发病风险呈线性剂量反应关系,其中收缩压水平是最重要的影响因素。
{"title":"Associations of Combined Exposure to Metabolic and Inflammatory Indicators with Thyroid Nodules in Adults: A Nested Case-Control Study","authors":"Xin-Yi Zhu, Xing-Chen Meng, Bei-Jing Cheng, Chun Wang, Jia Wang, Tian-Lin Li, Hui Li, Ke Meng, Ran Liu","doi":"10.1155/2024/3950894","DOIUrl":"https://doi.org/10.1155/2024/3950894","url":null,"abstract":"<i>Objective</i>. To explore associations of combined exposure to metabolic/inflammatory indicators with thyroid nodules. <i>Methods</i>. We reviewed personal data for health screenings from 2020 to 2021. A propensity score matching method was used to match 931 adults recently diagnosed with thyroid nodules in a 1 : 4 ratio based on age and gender. Conditional logistic regression and Bayesian kernel machine regression (BKMR) were used to explore the associations of single metabolic/inflammatory indicators and the mixture with thyroid nodules, respectively. <i>Results</i>. In the adjusted models, five indicators (OR<sub>Q4 vs. Q1</sub>: 1.30, 95% CI: 1.07–1.58 for fasting blood glucose; OR<sub>Q4 vs. Q1</sub>: 1.30, 95% CI: 1.08–1.57 for systolic blood pressure; OR<sub>Q4 vs. Q1</sub>: 1.26, 95% CI: 1.04–1.53 for diastolic blood pressure; OR<sub>Q4 vs. Q1</sub>: 1.23, 95% CI: 1.02–1.48 for white blood cell; OR<sub>Q4 vs. Q1</sub>: 1.28, 95% CI: 1.07–1.55 for neutrophil) were positively associated with the risk of thyroid nodules, while high-density lipoproteins (OR<sub>Q3 vs. Q1</sub>: 0.75, 95% CI: 0.61–0.91) were negatively associated with the risk of thyroid nodules. Univariate exposure-response functions from BKMR models showed similar results. Moreover, the metabolic and inflammatory mixture exhibited a significant positive association with thyroid nodules in a dose-response pattern, with systolic blood pressure being the greatest contributor within the mixture (conditional posterior inclusion probability of 0.82). No interaction effects were found among the five indicators. These associations were more prominent in males, participants with higher age (≥40 years old), and individuals with abnormal body mass index status. <i>Conclusions</i>. Levels of the metabolic and inflammatory mixture have a linear dose-response relationship with the risk of developing thyroid nodules, with systolic blood pressure levels being the most important contributor.","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"43 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140315133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coenzyme Q10: A Key Antioxidant in the Management of Diabetes-Induced Cardiovascular Complications—An Overview of Mechanisms and Clinical Evidence 辅酶Q10:治疗糖尿病引发的心血管并发症的关键抗氧化剂--机制与临床证据概述
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-15 DOI: 10.1155/2024/2247748
Fatemeh Samimi, Nasim Namiranian, Ali Sharifi-Rigi, Morvarid Siri, Omid Abazari, Sanaz Dastghaib
Background. Diabetes mellitus (DM) presents a significant global health challenge with considerable cardiovascular implications. Coenzyme Q10 (CoQ10) has gained recognition for its potential as a natural antioxidant supplement in the management of diabetes and its associated cardiovascular complications. Aim. This comprehensive review systematically examines the scientific rationale underlying the therapeutic properties of CoQ10 in mitigating the impact of diabetes and its cardiovascular consequences. The analysis encompasses preclinical trials (in vitro and in vivo) and clinical studies evaluating the efficacy and mechanisms of action of CoQ10. Result & Discussion. Findings reveal that CoQ10, through its potent antioxidant and anti-inflammatory attributes, demonstrates significant potential in reducing oxidative stress, ameliorating lipid profiles, and regulating blood pressure, which are crucial aspects in managing diabetes-induced cardiovascular complications. CoQ10, chemically represented as C59H90O4, was administered in capsule form for human studies at doses of 50, 100, 150, 200, and 300 mg per day and at concentrations of 10 and 20 μM in sterile powder for experimental investigations and 10 mg/kg in powder for mouse studies, according to the published research. Clinical trials corroborate these preclinical findings, demonstrating improved glycemic control, lipid profiles, and blood pressure in patients supplemented with CoQ10. Conclusion. In conclusion, CoQ10 emerges as a promising natural therapeutic intervention for the comprehensive management of diabetes and its associated cardiovascular complications. Its multifaceted impacts on the Nrf2/Keap1/ARE pathway, oxidative stress, and metabolic regulation highlight its potential as an adjunct in the treatment of diabetes and related cardiovascular disorders. However, further extensive clinical investigations are necessary to fully establish its therapeutic potential and assess potential synergistic effects with other compounds.
背景。糖尿病(DM)是一项重大的全球性健康挑战,对心血管有相当大的影响。辅酶 Q10(CoQ10)作为一种天然抗氧化剂补充剂,在治疗糖尿病及其相关心血管并发症方面的潜力已得到认可。目的。本综述系统地研究了辅酶 Q10 在减轻糖尿病及其心血管后果方面的治疗特性的科学依据。分析包括临床前试验(体外和体内)和临床研究,评估 CoQ10 的功效和作用机制。结果与讨论。研究结果表明,CoQ10 具有强大的抗氧化和抗炎特性,在减少氧化应激、改善血脂状况和调节血压方面具有巨大的潜力,而这正是控制糖尿病引发的心血管并发症的关键所在。根据发表的研究报告,CoQ10 的化学名称为 C59H90O4,在人体研究中以胶囊形式给药,剂量为每天 50、100、150、200 和 300 毫克,在实验研究中以浓度为 10 和 20 μM 的无菌粉末给药,在小鼠研究中以浓度为 10 毫克/千克的粉末给药。临床试验证实了这些临床前研究结果,显示补充辅酶Q10的患者血糖控制、血脂状况和血压都有所改善。结论总之,CoQ10 是一种很有前景的自然疗法干预措施,可用于糖尿病及其相关心血管并发症的综合治疗。CoQ10 对 Nrf2/Keap1/ARE 通路、氧化应激和代谢调节的多方面影响,凸显了其作为糖尿病及相关心血管疾病辅助治疗的潜力。不过,要充分确定其治疗潜力并评估其与其他化合物的潜在协同作用,还需要进一步开展广泛的临床研究。
{"title":"Coenzyme Q10: A Key Antioxidant in the Management of Diabetes-Induced Cardiovascular Complications—An Overview of Mechanisms and Clinical Evidence","authors":"Fatemeh Samimi, Nasim Namiranian, Ali Sharifi-Rigi, Morvarid Siri, Omid Abazari, Sanaz Dastghaib","doi":"10.1155/2024/2247748","DOIUrl":"https://doi.org/10.1155/2024/2247748","url":null,"abstract":"<i>Background</i>. Diabetes mellitus (DM) presents a significant global health challenge with considerable cardiovascular implications. Coenzyme Q10 (CoQ10) has gained recognition for its potential as a natural antioxidant supplement in the management of diabetes and its associated cardiovascular complications. <i>Aim</i>. This comprehensive review systematically examines the scientific rationale underlying the therapeutic properties of CoQ10 in mitigating the impact of diabetes and its cardiovascular consequences. The analysis encompasses preclinical trials (<i>in vitro</i> and <i>in vivo</i>) and clinical studies evaluating the efficacy and mechanisms of action of CoQ10. <i>Result &amp; Discussion</i>. Findings reveal that CoQ10, through its potent antioxidant and anti-inflammatory attributes, demonstrates significant potential in reducing oxidative stress, ameliorating lipid profiles, and regulating blood pressure, which are crucial aspects in managing diabetes-induced cardiovascular complications. CoQ10, chemically represented as C<sub>59</sub>H<sub>90</sub>O<sub>4</sub>, was administered in capsule form for human studies at doses of 50, 100, 150, 200, and 300 mg per day and at concentrations of 10 and 20 <i>μ</i>M in sterile powder for experimental investigations and 10 mg/kg in powder for mouse studies, according to the published research. Clinical trials corroborate these preclinical findings, demonstrating improved glycemic control, lipid profiles, and blood pressure in patients supplemented with CoQ10. <i>Conclusion</i>. In conclusion, CoQ10 emerges as a promising natural therapeutic intervention for the comprehensive management of diabetes and its associated cardiovascular complications. Its multifaceted impacts on the Nrf2/Keap1/ARE pathway, oxidative stress, and metabolic regulation highlight its potential as an adjunct in the treatment of diabetes and related cardiovascular disorders. However, further extensive clinical investigations are necessary to fully establish its therapeutic potential and assess potential synergistic effects with other compounds.","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"23 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140152916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Glycosylated Hemoglobin and Serum Uric Acid: A US NHANES 2011–2020 糖化血红蛋白与血清尿酸之间的关系:2011-2020 年美国国家健康调查
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-14 DOI: 10.1155/2024/5341646
Huan Li, Mingliang Sun, Chengcheng Huang, Jingwu Wang, Yanqin Huang
Background. Serum uric acid (SUA) and glycosylated hemoglobin (HbA1c) were closely related to the body’s metabolism. This study aimed to investigate the relationship between HbA1c and SUA in adults. Methods. This study selected 7293 participants aged ≥20 from 2011 to 2020 in the National Health and Nutrition Examination Survey (NHANES). The multivariate linear regression model was used to test the association between HbA1c and SUA. Subgroup analysis was performed according to age, gender, race, and body mass index (BMI). This study solved the relationship between HbA1c and SUA by fitting a smooth curve. Finally, the inflection point in the nonlinear relationship was calculated by the recursive algorithm, and the relationship between HbA1c and SUA on both sides of the inflection point was analyzed by the two-segment piecewise linear regression model. Results. All 7293 participants found a negative correlation between HbA1c and SUA by completely adjusting the model (β = −7.93 and 95% CI: −9.49–−6.37). In addition, when this study was stratified by gender, age, race, and BMI status, this negative correlation was still statistically significant. In the subgroup analysis, we found that the relationship between the two had different results due to gender differences. In men, HbA1c had a significant negative correlation with SUA. However, in women, the HbA1c value was positively correlated with SUA before 6.8%, and the HbA1c value was negatively correlated with SUA after 6.8%, which indicates that the relationship between HbA1c and SUA in women has changed in prediabetes and diabetes. Conclusion. This study shows that HbA1c is positively correlated with SUA in American adults before 7%. There is a negative correlation after the HbA1c value of 7%.
背景:血清尿酸(SUA)和糖化血红蛋白(HbA1c血清尿酸(SUA)和糖化血红蛋白(HbA1c)与人体新陈代谢密切相关。本研究旨在调查成人 HbA1c 和 SUA 之间的关系。研究方法本研究选取了美国国家健康与营养调查(NHANES)中 2011 年至 2020 年年龄≥20 岁的 7293 名参与者。采用多变量线性回归模型检验 HbA1c 与 SUA 之间的关联。根据年龄、性别、种族和体重指数(BMI)进行了分组分析。这项研究通过拟合一条平滑的曲线来解决 HbA1c 和 SUA 之间的关系。最后,通过递归算法计算出非线性关系的拐点,并通过两段分段线性回归模型分析拐点两侧 HbA1c 和 SUA 的关系。结果显示通过完全调整模型,发现所有 7293 名参与者的 HbA1c 与 SUA 之间均呈负相关(β = -7.93,95% CI:-9.49--6.37)。此外,当该研究按性别、年龄、种族和体重指数状况进行分层时,这种负相关关系在统计学上仍然显著。在亚组分析中,我们发现两者之间的关系因性别差异而有不同的结果。在男性中,HbA1c 与 SUA 呈显著负相关。但在女性中,6.8%之前的HbA1c值与SUA呈正相关,6.8%之后的HbA1c值与SUA呈负相关,这表明在糖尿病前期和糖尿病中,女性HbA1c与SUA之间的关系发生了变化。结论本研究表明,美国成年人的 HbA1c 值在 7% 之前与 SUA 值呈正相关。在 HbA1c 值达到 7% 之后则呈负相关。
{"title":"Association between Glycosylated Hemoglobin and Serum Uric Acid: A US NHANES 2011–2020","authors":"Huan Li, Mingliang Sun, Chengcheng Huang, Jingwu Wang, Yanqin Huang","doi":"10.1155/2024/5341646","DOIUrl":"https://doi.org/10.1155/2024/5341646","url":null,"abstract":"<i>Background</i>. Serum uric acid (SUA) and glycosylated hemoglobin (HbA1c) were closely related to the body’s metabolism. This study aimed to investigate the relationship between HbA1c and SUA in adults. <i>Methods</i>. This study selected 7293 participants aged ≥20 from 2011 to 2020 in the National Health and Nutrition Examination Survey (NHANES). The multivariate linear regression model was used to test the association between HbA1c and SUA. Subgroup analysis was performed according to age, gender, race, and body mass index (BMI). This study solved the relationship between HbA1c and SUA by fitting a smooth curve. Finally, the inflection point in the nonlinear relationship was calculated by the recursive algorithm, and the relationship between HbA1c and SUA on both sides of the inflection point was analyzed by the two-segment piecewise linear regression model. <i>Results</i>. All 7293 participants found a negative correlation between HbA1c and SUA by completely adjusting the model (<i>β</i> = −7.93 and 95% CI: −9.49–−6.37). In addition, when this study was stratified by gender, age, race, and BMI status, this negative correlation was still statistically significant. In the subgroup analysis, we found that the relationship between the two had different results due to gender differences. In men, HbA1c had a significant negative correlation with SUA. However, in women, the HbA1c value was positively correlated with SUA before 6.8%, and the HbA1c value was negatively correlated with SUA after 6.8%, which indicates that the relationship between HbA1c and SUA in women has changed in prediabetes and diabetes. <i>Conclusion</i>. This study shows that HbA1c is positively correlated with SUA in American adults before 7%. There is a negative correlation after the HbA1c value of 7%.","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"21 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140124809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches 抗糖尿病药物作为二甲双胍附加疗法对多囊卵巢综合征妇女的疗效比较:代谢疗法的系统回顾
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-11 DOI: 10.1155/2024/9900213
Maryam Heidarpour, Mehrzad Mojarad, Sadegh Mazaheri-Tehrani, Ali Kachuei, Arash Najimi, Davood Shafie, Hassan Rezvanian
Background. Metformin is commonly prescribed to treat polycystic ovary syndrome (PCOS) patients, but in some cases, it may not be effective even at high doses or may cause intolerable side effects. Therefore, recent studies have examined the impact of combining metformin with other antidiabetic medications. Methods. A systematic search was performed in Scopus, PubMed, Web of Science, and Embase up to 30 June 2023. All interventional studies that assessed the efficacy of different antidiabetic agents were included. Results. Among the 3488 records found in the primary search, 16 papers were included. Our study showed that dipeptidyl peptidase-4 inhibitors (DPP4i) had the most significant impact on glycemic profile, while thiazolidinediones (TZDs) had the most influence on lipid levels. However, it was observed that patients taking only metformin experienced a greater increase in high-density lipoprotein cholesterol (HDL-C) levels. Glucagon-like peptide-1 receptor agonists (GLP1RAs) effectively modified various anthropometric measurements, such as weight, body mass index, waist circumference, and waist-to-hip ratio. The effects of different antidiabetic drugs on hormone levels were inconclusive, although testosterone levels were more affected by GLP1RA, sodium-glucose cotransporter-2 inhibitors (SGLT2i), and TZDs. None of the combined therapies showed a significant change in blood pressure. Conclusion. Since PCOS is a metabolic disorder, choosing the best combination of antidiabetic drugs in the clinical course of PCOS patients will be very important. Today, it seems that we need a new metabolic approach for better treatment of the metabolic aspects of these patients.
背景。二甲双胍是治疗多囊卵巢综合征(PCOS)患者的常用处方药,但在某些情况下,即使服用大剂量二甲双胍也可能无效,或者会产生难以忍受的副作用。因此,最近有研究探讨了二甲双胍与其他抗糖尿病药物联合使用的影响。研究方法截至 2023 年 6 月 30 日,在 Scopus、PubMed、Web of Science 和 Embase 中进行了系统检索。纳入了所有评估不同抗糖尿病药物疗效的干预性研究。结果。在主要搜索中发现的 3488 条记录中,有 16 篇论文被收录。我们的研究表明,二肽基肽酶-4 抑制剂(DPP4i)对血糖谱的影响最大,而噻唑烷二酮类药物(TZDs)对血脂水平的影响最大。不过,据观察,只服用二甲双胍的患者的高密度脂蛋白胆固醇(HDL-C)水平增幅更大。胰高血糖素样肽-1 受体激动剂(GLP1RAs)能有效改善各种人体测量指标,如体重、体重指数、腰围和腰臀比。不同抗糖尿病药物对激素水平的影响尚无定论,但睾酮水平受 GLP1RA、钠-葡萄糖共转运体-2 抑制剂(SGLT2i)和 TZDs 的影响较大。没有一种联合疗法显示血压有明显变化。结论由于多囊卵巢综合征是一种代谢性疾病,在多囊卵巢综合征患者的临床治疗过程中,选择最佳的抗糖尿病药物组合将非常重要。如今,我们似乎需要一种新的代谢方法来更好地治疗这些患者的代谢问题。
{"title":"Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches","authors":"Maryam Heidarpour, Mehrzad Mojarad, Sadegh Mazaheri-Tehrani, Ali Kachuei, Arash Najimi, Davood Shafie, Hassan Rezvanian","doi":"10.1155/2024/9900213","DOIUrl":"https://doi.org/10.1155/2024/9900213","url":null,"abstract":"<i>Background</i>. Metformin is commonly prescribed to treat polycystic ovary syndrome (PCOS) patients, but in some cases, it may not be effective even at high doses or may cause intolerable side effects. Therefore, recent studies have examined the impact of combining metformin with other antidiabetic medications. <i>Methods</i>. A systematic search was performed in Scopus, PubMed, Web of Science, and Embase up to 30 June 2023. All interventional studies that assessed the efficacy of different antidiabetic agents were included. <i>Results</i>. Among the 3488 records found in the primary search, 16 papers were included. Our study showed that dipeptidyl peptidase-4 inhibitors (DPP4i) had the most significant impact on glycemic profile, while thiazolidinediones (TZDs) had the most influence on lipid levels. However, it was observed that patients taking only metformin experienced a greater increase in high-density lipoprotein cholesterol (HDL-C) levels. Glucagon-like peptide-1 receptor agonists (GLP1RAs) effectively modified various anthropometric measurements, such as weight, body mass index, waist circumference, and waist-to-hip ratio. The effects of different antidiabetic drugs on hormone levels were inconclusive, although testosterone levels were more affected by GLP1RA, sodium-glucose cotransporter-2 inhibitors (SGLT2i), and TZDs. None of the combined therapies showed a significant change in blood pressure. <i>Conclusion</i>. Since PCOS is a metabolic disorder, choosing the best combination of antidiabetic drugs in the clinical course of PCOS patients will be very important. Today, it seems that we need a new metabolic approach for better treatment of the metabolic aspects of these patients.","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"23 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140099784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analysis of the Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma: A Follow-Up Study of Continuous Postoperative Surveillance and Large-Sample Data 超声引导下射频消融治疗甲状腺乳头状微癌的有效性和安全性回顾性分析:术后持续监测和大样本数据随访研究
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-06 DOI: 10.1155/2024/2704087
Gongli Zhou, Xuefeng Zhang, Ke Xu, Beibei Zhang, Ruiqing Su, Tingting Cai, Wei Zhao, Feng Li
Objective. To retrospectively evaluate the efficacy and safety of ultrasound-guided radiofrequency ablation (RFA) in the treatment of papillary thyroid microcarcinoma (PTMC) through a follow-up study of continuous postoperative surveillance and large-sample data. Methods. The efficacy of ultrasound-guided RFA was evaluated by measuring the tumor volume reduction rate (VRR), tumor disappearance rate, and disease progression in 358 patients with low-risk unifocal PTMC who underwent ultrasound-guided RFA at Hangzhou Weja Hospital, while the safety was evaluated by measuring their complications. Results. The VRR was −745.69 ± 1012.69 (%), −150.35 ± 395.5 (%), 46.47 ± 138.74 (%), 92.95 ± 27.88 (%), 97.78 ± 10.99 (%), and 99.27 ± 3.82 (%), respectively, at 1, 3, 6, 12, 18, and 24 months after RFA. The corresponding tumor disappearance rate was 1.68%, 9.78%, 43.85%, 82.68%, 92.59%, and 95.63%, respectively. No local recurrence, new tumors, lymph node metastasis, distant metastasis, and deaths caused by recurrent/metastatic PTMC were found at the last follow-up. Except for 3 cases (0.84%) with thickening or hoarseness of voice and 3 cases (0.84%) with coughing during drinking water, no other complications were found. Conclusions. Ultrasound-guided RFA has good efficacy and safety for the treatment of low-risk unifocal PTMC and can be promoted for use in patients who meet the required indications.
目的通过术后连续监测和大样本数据的随访研究,回顾性评估超声引导下射频消融(RFA)治疗甲状腺乳头状微癌(PTMC)的有效性和安全性。研究方法通过测量在杭州维佳医院接受超声引导射频消融术的358例低风险单灶PTMC患者的肿瘤体积缩小率(VRR)、肿瘤消失率和疾病进展情况,评估超声引导射频消融术的疗效;通过测量并发症情况,评估超声引导射频消融术的安全性。结果显示RFA术后1、3、6、12、18和24个月的VRR分别为-745.69±1012.69(%)、-150.35±395.5(%)、46.47±138.74(%)、92.95±27.88(%)、97.78±10.99(%)和99.27±3.82(%)。相应的肿瘤消失率分别为 1.68%、9.78%、43.85%、82.68%、92.59% 和 95.63%。最后一次随访时,未发现复发/转移性 PTMC 导致的局部复发、新肿瘤、淋巴结转移、远处转移和死亡。除了 3 例(0.84%)患者声音变粗或嘶哑,以及 3 例(0.84%)患者在喝水时咳嗽外,未发现其他并发症。结论超声引导下射频消融术治疗低风险单灶 PTMC 具有良好的疗效和安全性,可推广用于符合所需适应症的患者。
{"title":"Retrospective Analysis of the Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma: A Follow-Up Study of Continuous Postoperative Surveillance and Large-Sample Data","authors":"Gongli Zhou, Xuefeng Zhang, Ke Xu, Beibei Zhang, Ruiqing Su, Tingting Cai, Wei Zhao, Feng Li","doi":"10.1155/2024/2704087","DOIUrl":"https://doi.org/10.1155/2024/2704087","url":null,"abstract":"<i>Objective</i>. To retrospectively evaluate the efficacy and safety of ultrasound-guided radiofrequency ablation (RFA) in the treatment of papillary thyroid microcarcinoma (PTMC) through a follow-up study of continuous postoperative surveillance and large-sample data. <i>Methods</i>. The efficacy of ultrasound-guided RFA was evaluated by measuring the tumor volume reduction rate (VRR), tumor disappearance rate, and disease progression in 358 patients with low-risk unifocal PTMC who underwent ultrasound-guided RFA at Hangzhou Weja Hospital, while the safety was evaluated by measuring their complications. <i>Results</i>. The VRR was −745.69 ± 1012.69 (%), −150.35 ± 395.5 (%), 46.47 ± 138.74 (%), 92.95 ± 27.88 (%), 97.78 ± 10.99 (%), and 99.27 ± 3.82 (%), respectively, at 1, 3, 6, 12, 18, and 24 months after RFA. The corresponding tumor disappearance rate was 1.68%, 9.78%, 43.85%, 82.68%, 92.59%, and 95.63%, respectively. No local recurrence, new tumors, lymph node metastasis, distant metastasis, and deaths caused by recurrent/metastatic PTMC were found at the last follow-up. Except for 3 cases (0.84%) with thickening or hoarseness of voice and 3 cases (0.84%) with coughing during drinking water, no other complications were found. <i>Conclusions</i>. Ultrasound-guided RFA has good efficacy and safety for the treatment of low-risk unifocal PTMC and can be promoted for use in patients who meet the required indications.","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"52 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140046979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Hypogonadism and Associated Risk Factors among Newly Diagnosed ART Naïve HIV-Infected Males in Mwanza, Tanzania 坦桑尼亚姆万扎新确诊的抗逆转录病毒疗法(ART)免疫缺陷病毒感染男性中性腺功能减退症的患病率及相关风险因素
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-05 DOI: 10.1155/2024/9679935
Shabani Iddi, Haruna Dika, Benson Kidenya, Samuel Kalluvya
<i>Background</i>. Hypogonadism is frequent among HIV-infected males and might have significant clinical impact leading to sexual impairment and metabolic derangement. There is limited information about the magnitude of hypogonadism and its associated factors among people living with HIV in Tanzania. We aimed to determine the prevalence of hypogonadism and associated risk factors among newly diagnosed ART naïve HIV-infected men in Mwanza, Tanzania. <i>Methods</i>. Newly diagnosed ART naïve HIV-infected men were enrolled at Voluntary Counseling and Testing Centres of four selected hospitals in the Mwanza region and subjected to thorough clinical and general physical examination including anthropometric measurements. A prestructured questionnaire was used to collect sociodemographic characteristics and clinical data. Serum total testosterone, follicle-stimulating hormone, luteinizing hormone, and estradiol were estimated. Serum total testosterone <300 ng/dl or testosterone >300 ng/dl with high LH and FSH (compensatory hypogonadism) was taken as markers of hypogonadism. Data were analyzed using STATA version 15. <i>Results</i>. Of the 388 enrolled participants, hypogonadism was found in 47.9%, with secondary hypogonadism (83.9%, 156/186) being the most frequent form. Logistic regression analysis showed a significant association between hypogonadism and CD4+ count (OR 2.0; 95% CI 1.1–3.6; <span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 18.973 11.7782" width="18.973pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"></path></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"></path></g></svg><span></span><span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="22.555183800000002 -8.34882 28.184 11.7782" width="28.184pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,22.605,0)"></path></g><g transform="matrix(.013,0,0,-0.013,28.845,0)"></path></g><g transform="matrix(.013,0,0,-0.013,31.809,0)"><use xlink:href="#g113-49"></use></g><g transform="matrix(.013,0,0,-0.013,38.049,0)"></path></g><g transform="matrix(.013,0,0,-0.013,44.289,0)"><use xlink:href="#g113-51"></use></g></svg>),</span></span> decreased libido (OR 1.6; 95% CI 1.1–2.4; <span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 18.973 11.7782" width="18.973pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><use xlink:href="#g113-113"></use></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"><use xlink:href="#g117-34"></use></g></svg><span></span><span><svg height="11.7782pt" style="vertical-align:-3.42938pt" version="1.1" viewbox="22.555183800000002 -8.34882 28.184 11.7782" width="28.184pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink=
背景。性腺功能减退症在感染艾滋病毒的男性中很常见,可能会对临床产生重大影响,导致性功能障碍和新陈代谢失调。关于坦桑尼亚 HIV 感染者中性腺功能减退症的严重程度及其相关因素的信息非常有限。我们旨在确定坦桑尼亚姆万扎新诊断出的抗逆转录病毒疗法未接受治疗的男性 HIV 感染者中性腺功能减退症的发病率及其相关风险因素。研究方法在姆万扎地区选定的四家医院的自愿咨询和检测中心对新诊断出的抗逆转录病毒疗法未接受过治疗的男性艾滋病病毒感染者进行登记,并对他们进行全面的临床和一般体格检查,包括人体测量。他们接受了包括人体测量在内的全面临床和一般体格检查,并使用一份预设问卷收集社会人口学特征和临床数据。对血清总睾酮、卵泡刺激素、黄体生成素和雌二醇进行了估测。血清总睾酮<300 ng/dl或睾酮<300 ng/dl同时伴有高LH和FSH(代偿性性腺功能减退症)作为性腺功能减退症的标志。数据使用 STATA 15 版进行分析。结果在 388 名参加者中,47.9% 发现了性腺功能减退症,其中最常见的是继发性性腺功能减退症(83.9%,156/186)。4; )、年龄在 46 岁以上(OR 2.3;95% CI 1.1-4.6; )、服用中药(OR 2.4;95% CI 1.5-3.9; )、WHO 临床 3 期(OR 2.7;95% CI 1.4-5.2; )和体重减轻(OR 1.8;95% CI 1.1-3.0; )。结论近一半(47.9%)抗逆转录病毒疗法未达标的男性艾滋病感染者存在性腺功能减退症。大多数(83.9%)患有继发性性腺功能减退症。性腺功能减退与年龄偏大、服用中药、体重减轻、临床晚期、CD4+计数和性欲减退有明显关联。
{"title":"Prevalence of Hypogonadism and Associated Risk Factors among Newly Diagnosed ART Naïve HIV-Infected Males in Mwanza, Tanzania","authors":"Shabani Iddi, Haruna Dika, Benson Kidenya, Samuel Kalluvya","doi":"10.1155/2024/9679935","DOIUrl":"https://doi.org/10.1155/2024/9679935","url":null,"abstract":"&lt;i&gt;Background&lt;/i&gt;. Hypogonadism is frequent among HIV-infected males and might have significant clinical impact leading to sexual impairment and metabolic derangement. There is limited information about the magnitude of hypogonadism and its associated factors among people living with HIV in Tanzania. We aimed to determine the prevalence of hypogonadism and associated risk factors among newly diagnosed ART naïve HIV-infected men in Mwanza, Tanzania. &lt;i&gt;Methods&lt;/i&gt;. Newly diagnosed ART naïve HIV-infected men were enrolled at Voluntary Counseling and Testing Centres of four selected hospitals in the Mwanza region and subjected to thorough clinical and general physical examination including anthropometric measurements. A prestructured questionnaire was used to collect sociodemographic characteristics and clinical data. Serum total testosterone, follicle-stimulating hormone, luteinizing hormone, and estradiol were estimated. Serum total testosterone &lt;300 ng/dl or testosterone &gt;300 ng/dl with high LH and FSH (compensatory hypogonadism) was taken as markers of hypogonadism. Data were analyzed using STATA version 15. &lt;i&gt;Results&lt;/i&gt;. Of the 388 enrolled participants, hypogonadism was found in 47.9%, with secondary hypogonadism (83.9%, 156/186) being the most frequent form. Logistic regression analysis showed a significant association between hypogonadism and CD4+ count (OR 2.0; 95% CI 1.1–3.6; &lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.34882 18.973 11.7782\" width=\"18.973pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.342,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"22.555183800000002 -8.34882 28.184 11.7782\" width=\"28.184pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,22.605,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,28.845,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,31.809,0)\"&gt;&lt;use xlink:href=\"#g113-49\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,38.049,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,44.289,0)\"&gt;&lt;use xlink:href=\"#g113-51\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;/svg&gt;),&lt;/span&gt;&lt;/span&gt; decreased libido (OR 1.6; 95% CI 1.1–2.4; &lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.34882 18.973 11.7782\" width=\"18.973pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;use xlink:href=\"#g113-113\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,11.342,0)\"&gt;&lt;use xlink:href=\"#g117-34\"&gt;&lt;/use&gt;&lt;/g&gt;&lt;/svg&gt;&lt;span&gt;&lt;/span&gt;&lt;span&gt;&lt;svg height=\"11.7782pt\" style=\"vertical-align:-3.42938pt\" version=\"1.1\" viewbox=\"22.555183800000002 -8.34882 28.184 11.7782\" width=\"28.184pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"1 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140033511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of the AADE7 Self-Care Behaviors Framework on Diabetes Education Management in a Shared Care Model AADE7 自我护理行为框架对共同护理模式下糖尿病教育管理的影响
IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-03-01 DOI: 10.1155/2024/7278207
Yunxia Liu, Chenhui Liu
<i>Background</i>. Diabetes self-management education (DSME) provides diabetic patients with knowledge of diabetes, requires attention and recording of dietary habits, and increases the frequency and accuracy of blood glucose monitoring. DSME also achieves better blood glucose control, thus benefiting diabetic patients and reducing the risk of diabetes complications. However, few studies have systematically examined whether DSME follows AADE 7 Self-Care Behaviors (AADE7™). Therefore, this study aimed to investigate the control effect of AADE7™-based management on laboratory test indicators of diabetic patients. <i>Methods</i>. The patients with diabetes who received shared care management in our hospital between June 2014 and April 2022 were analyzed retrospectively. According to the process of outpatient consultation, each patient received health education provided by diabetes education nurses and dietitians after consultation. Health education was a process from assessment to health guidance. The basic information of all patients was recorded, and AADE7™ behavior assessment and health education session were conducted through interviews. A total of 13,650 were given shared care management, requiring more than 6 follow-up visits per year, as well as health education. It was reassessed annually according to AADE standards. The impact of the patients’ behavior change after the AADE7™-based management on the relevant test indicators was observed. <i>Results</i>. After eight years of intervention, a total of 8319 samples were obtained after excluding the outliers. Stepwise regression analysis was performed, and the results showed that, with other conditions held constant, a greater number of days per week to follow a healthy diet, to take hypoglycemic medication as prescribed, to monitor blood glucose, and to exercise and higher education level were associated with lower levels of glycosylated hemoglobin. The change from drinking to nondrinking was associated with lower triglycerides. If low blood glucose was monitored, patients who reviewed and took immediate action showed lower levels of low-density lipoprotein, urine microalbumin, and urine microalbumin/creatinine ratio compared with those without review and immediate action. Significance tests for each term showed <svg height="8.68572pt" style="vertical-align:-0.0498209pt" version="1.1" viewbox="-0.0498162 -8.6359 8.15071 8.68572" width="8.15071pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"></path></g></svg> value <0.05. <i>Conclusions</i>. The AADE7™ framework is a tool supporting patient-centered self-management and education. In the AADE7™ standards, successful self-management is considered as a key outcome in the care of patients with diabetes and related diseases. This tool can effectively improve patient compliance and increase the rate of blood glucose compliance rates in patients with diabetes and therefore i
背景。糖尿病自我管理教育(DSME)为糖尿病患者提供糖尿病知识,要求注意和记录饮食习惯,增加血糖监测的频率和准确性。糖尿病自我管理教育还能更好地控制血糖,从而使糖尿病患者受益并降低糖尿病并发症的风险。然而,很少有研究系统性地探讨 DSME 是否遵循 AADE 7 自我护理行为(AADE7™)。因此,本研究旨在探讨基于 AADE7™ 的管理对糖尿病患者化验指标的控制效果。研究方法回顾性分析2014年6月至2022年4月期间在我院接受共享护理管理的糖尿病患者。根据门诊就诊流程,每位患者在就诊后均接受了由糖尿病教育护士和营养师提供的健康教育。健康教育是一个从评估到健康指导的过程。对所有患者的基本信息进行记录,并通过访谈进行 AADE7™ 行为评估和健康教育。共有 13650 人接受了共同护理管理,每年需要进行 6 次以上的随访,并接受健康教育。根据 AADE 标准,每年进行一次重新评估。观察基于 AADE7™ 的管理后患者行为改变对相关检测指标的影响。结果显示经过八年的干预,在排除异常值后,共获得 8319 个样本。进行了逐步回归分析,结果表明,在其他条件不变的情况下,每周坚持健康饮食、遵医嘱服用降糖药、监测血糖、运动的天数越多,受教育程度越高,糖化血红蛋白水平越低。从酗酒到不酗酒与甘油三酯降低有关。如果监测到低血糖,复查并立即采取行动的患者与未复查并立即采取行动的患者相比,低密度脂蛋白、尿微量白蛋白和尿微量白蛋白/肌酐比值水平较低。每项指标的显著性检验值均为 <0.05。结论:AADE7AADE7™ 框架是一种支持以患者为中心的自我管理和教育的工具。在 AADE7™ 标准中,成功的自我管理被视为糖尿病及相关疾病患者护理的关键成果。该工具可有效改善患者的依从性,提高糖尿病患者的血糖达标率,因此值得临床推广。
{"title":"Effect of the AADE7 Self-Care Behaviors Framework on Diabetes Education Management in a Shared Care Model","authors":"Yunxia Liu, Chenhui Liu","doi":"10.1155/2024/7278207","DOIUrl":"https://doi.org/10.1155/2024/7278207","url":null,"abstract":"&lt;i&gt;Background&lt;/i&gt;. Diabetes self-management education (DSME) provides diabetic patients with knowledge of diabetes, requires attention and recording of dietary habits, and increases the frequency and accuracy of blood glucose monitoring. DSME also achieves better blood glucose control, thus benefiting diabetic patients and reducing the risk of diabetes complications. However, few studies have systematically examined whether DSME follows AADE 7 Self-Care Behaviors (AADE7™). Therefore, this study aimed to investigate the control effect of AADE7™-based management on laboratory test indicators of diabetic patients. &lt;i&gt;Methods&lt;/i&gt;. The patients with diabetes who received shared care management in our hospital between June 2014 and April 2022 were analyzed retrospectively. According to the process of outpatient consultation, each patient received health education provided by diabetes education nurses and dietitians after consultation. Health education was a process from assessment to health guidance. The basic information of all patients was recorded, and AADE7™ behavior assessment and health education session were conducted through interviews. A total of 13,650 were given shared care management, requiring more than 6 follow-up visits per year, as well as health education. It was reassessed annually according to AADE standards. The impact of the patients’ behavior change after the AADE7™-based management on the relevant test indicators was observed. &lt;i&gt;Results&lt;/i&gt;. After eight years of intervention, a total of 8319 samples were obtained after excluding the outliers. Stepwise regression analysis was performed, and the results showed that, with other conditions held constant, a greater number of days per week to follow a healthy diet, to take hypoglycemic medication as prescribed, to monitor blood glucose, and to exercise and higher education level were associated with lower levels of glycosylated hemoglobin. The change from drinking to nondrinking was associated with lower triglycerides. If low blood glucose was monitored, patients who reviewed and took immediate action showed lower levels of low-density lipoprotein, urine microalbumin, and urine microalbumin/creatinine ratio compared with those without review and immediate action. Significance tests for each term showed &lt;svg height=\"8.68572pt\" style=\"vertical-align:-0.0498209pt\" version=\"1.1\" viewbox=\"-0.0498162 -8.6359 8.15071 8.68572\" width=\"8.15071pt\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;g transform=\"matrix(.013,0,0,-0.013,0,0)\"&gt;&lt;/path&gt;&lt;/g&gt;&lt;/svg&gt; value &lt;0.05. &lt;i&gt;Conclusions&lt;/i&gt;. The AADE7™ framework is a tool supporting patient-centered self-management and education. In the AADE7™ standards, successful self-management is considered as a key outcome in the care of patients with diabetes and related diseases. This tool can effectively improve patient compliance and increase the rate of blood glucose compliance rates in patients with diabetes and therefore i","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"40 43 1","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140011593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1